UK Companies House feature
OPEROSE HEALTH (GROUP) UK LIMITED
Profile
- Company number
- 05555460
- Status
- Active
- Incorporation
- 2005-09-06
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86210
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Consolidated (group)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Affirmed
“The Directors have reviewed cash flow forecasts prepared at a consolidated level for a period of at least 12 months from the date of approval of these financial statements. These forecasts, which include reasonably possible downside scenarios, indicate that the Operose Health Group will have sufficient funds to meet its liabilities as they fall due. On this basis, the Directors consider it appropriate to prepare the financial statements on a going concern basis”
Significant events
- “During the prior period, as the Group moved towards focusing on primary and urgent care, the Group's community services division was closed, as these contracts came to the end of their natural contract length.”
- “£465k transaction and integration costs in 2024 reflect costs incurred in the change in ownership and subsequent review, reset and refocus of strategy resulting in some one off, non-recurrent costs as we implement and invest in new systems that would better help us to meet our strategic goals, realigned contracts and right-sized our corporate support functions.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HARDING, Nicholas John | Director | 2019-12-20 | Dec 1969 | British |
| MCKENZIE-BOYLE, Edward Charles Albert | Director | 2024-03-27 | Jan 1981 | English |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GODRICH, Francine | Secretary | 2012-04-24 | 2018-06-13 |
| HAMILL, William John | Secretary | 2011-11-28 | 2012-04-24 |
| HENDRIE, Neal Malcolm | Secretary | 2010-09-07 | 2011-08-12 |
| HUMPHREY, Shelley | Secretary | 2011-08-12 | 2011-11-28 |
| MILLEN, Karen Kai-Ling | Secretary | 2007-10-30 | 2010-09-07 |
| LAYTONS SECRETARIES LIMITED | Corporate Secretary | 2005-09-06 | 2007-10-30 |
| BRINKLEY, Cynthia Jane | Director | 2014-11-27 | 2016-01-18 |
| CHAN, Arvan See Wing | Director | 2016-01-18 | 2019-01-24 |
| DAVIES, Stephen John | Director | 2011-11-22 | 2013-04-02 |
| FORDYCE, Stuart Alistair | Director | 2008-05-27 | 2010-05-27 |
| HASTINGS, Roy | Director | 2014-05-30 | 2017-12-31 |
| HENDRIE, Neal Malcolm | Director | 2010-05-27 | 2011-08-12 |
| HOPKINS, Thomas William | Director | 2011-11-22 | 2014-04-22 |
| JOHNSON, Allan | Director | 2011-12-13 | 2018-01-31 |
| JONES, Samantha Geraldine | Director | 2019-01-24 | 2021-03-30 |
| KADIRGAMAR, Ajit Gordon Vimalendran, Dr | Director | 2005-09-06 | 2008-05-27 |
| MACFARLANE, Bruce Ferguson | Director | 2014-04-22 | 2016-09-29 |
| PERRY, Elizabeth Mary Louise | Director | 2021-03-29 | 2024-03-29 |
| RAVEN, Deborah Jane | Director | 2006-12-12 | 2011-10-14 |
| RHODES, Shaun Andrew | Director | 2006-10-10 | 2007-11-02 |
| ROSE, Jeremy David, Dr | Director | 2005-09-06 | 2019-12-31 |
| WATTS, Peter Martin | Director | 2005-09-06 | 2011-12-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Operose Health (Group) Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 141 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-18 | AA | accounts | accounts with accounts type full |
| 2026-04-03 | PARENT_ACC | accounts | legacy |
| 2026-04-03 | GUARANTEE2 | other | legacy |
| 2026-04-03 | RESOLUTIONS | resolution | resolution |
| 2025-09-23 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-04-11 | SH01 | capital | capital allotment shares |
| 2025-04-10 | RESOLUTIONS | resolution | resolution |
| 2025-04-02 | AA | accounts | accounts with accounts type total exemption full |
| 2025-04-02 | PARENT_ACC | accounts | legacy |
| 2025-04-02 | AGREEMENT2 | other | legacy |
| 2025-04-02 | GUARANTEE2 | other | legacy |
| 2025-03-26 | SH19 | capital | capital statement capital company with date currency figure |
| 2025-03-26 | SH20 | capital | legacy |
| 2025-03-26 | CAP-SS | insolvency | legacy |
| 2025-03-26 | RESOLUTIONS | resolution | resolution |
| 2024-09-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-08 | AA01 | accounts | change account reference date company previous extended |
| 2024-05-06 | AD01 | address | change registered office address company with date old address new address |
| 2024-04-02 | TM01 | officers | termination director company with name termination date |
| 2024-03-28 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory